Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Differential importance of endothelial and hematopoietic cell GLP-1Rs for cardiometabolic versus hepatic actions of semaglutide

JCI Insight(2021)10.1172/jci.insight.153732Source: DataRank Database

Differential importance of endothelial and hematopoietic cell GLP-1Rs for cardiometabolic versus hepatic actions of semaglutide is a research paper published in JCI Insight (2021). On theSindex it has a DataRank of 0. It has been cited 79 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access79 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 5.66)OA: goldTopics (55)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Chi Kin Wong ORCID,Kiran Deep Kaur,Randy J. Seeley ORCID,Daniel J. Drucker ORCID,Brent A. McLean ORCID

Live enrichment

PubMed:34673572 PMC:PMC8663785 OpenAlex:https://openalex.org/W3205468492

CIHR

Grant: 154321

Novo Nordisk Fonden

Grant: NNF19SA0035502

NIDDK NIH HHS

Grant: P30 DK020572

Canadian Institutes of Health Research

Grant: unidentified

unidentified

FWCI

5.66

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttp://insight.jci.org/articles/view/153732/files/pdf

publisherhttp://insight.jci.org/articles/view/153732/files/pdf

publisherhttps://insight.jci.org/articles/view/153732/files/pdf

journalhttps://doi.org/10.1172/jci.insight.153732

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34673572

Fields of Study

Diabetes Treatment and ManagementPancreatic function and diabetesMetabolism, Diabetes, and Cancer0301 basic medicine0303 health sciences03 medical and health sciencesAnimalsAtherosclerosisEndothelial CellsGlucagon-Like Peptide 1Glucagon-Like PeptidesHematopoietic Stem CellsHumansLiverMaleMetabolic SyndromeMiceSemaglutide

MeSH Terms

SemaglutideAnimalsGlucagon-Like PeptidesHematopoietic Stem CellsHumansLiverMaleMetabolic SyndromeEndothelial CellsAtherosclerosisMiceGlucagon-Like Peptide 1

Keywords

SemaglutideEndocrinologyInternal medicineSpleenBiologyBone marrowType 2 diabetesMedicineLiraglutideDiabetes mellitusPeptidesDiabetesMaleMetabolic SyndromeRGlucagon-Like PeptidesEndothelial CellsAtherosclerosisHematopoietic Stem CellsMiceLiverGlucagon-Like Peptide 1AnimalsHumansResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Differential importance of endothelial and hematopoietic cell GLP-1Rs for cardiometabolic versus hepatic actions of semaglutide

FAIR Checklist

Authors (5)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)